Alternate Health (OTCMKTS:AHGIF) versus Enovis (NYSE:ENOV) Head-To-Head Review

Alternate Health (OTCMKTS:AHGIF) and Enovis (NYSE:ENOV) are both medical companies, but which is the superior investment? We will contrast the two businesses based on the strength of their earnings, valuation, institutional ownership, risk, profitability, dividends and analyst recommendations.

Analyst Ratings

This is a breakdown of recent recommendations for Alternate Health and Enovis, as reported by MarketBeat.com.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Alternate Health	0	0	0	0	0.00
Enovis	1	0	7	2	3.00

Enovis has a consensus target price of $47.43, indicating a potential upside of 107.86%. Given Enovis’ stronger consensus rating and higher possible upside, analysts plainly believe Enovis is more favorable than Alternate Health.

Earnings & Valuation

This table compares Alternate Health and Enovis”s revenue, earnings per share and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Alternate Health	N/A	N/A	N/A	N/A	N/A
Enovis	$2.25 billion	0.58	-$1.18 billion	($20.71)	-1.10

Alternate Health has higher earnings, but lower revenue than Enovis.

Profitability

This table compares Alternate Health and Enovis’ net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Alternate Health	N/A	N/A	N/A
Enovis	-52.69%	8.74%	4.19%

Institutional & Insider Ownership

98.5% of Enovis shares are held by institutional investors. 2.7% of Enovis shares are held by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock will outperform the market over the long term.

Summary

Enovis beats Alternate Health on 9 of the 10 factors compared between the two stocks.

About Alternate Health

Alternate Health Corp., a diversified healthcare company, provides cloud based software solutions in Canada. It offers medical practice and controlled substance management software, blood analysis and toxicology labs, clinical research, continuing education programs, nutraceutical products, and security and control services to the medical cannabis industry. The company is headquartered in Toronto, Canada.

About Enovis

Enovis Corporation operates as a medical technology company focus on developing clinically differentiated solutions worldwide. It also manufactures and distributes medical devices which are used for reconstructive surgery, rehabilitation, pain management, and physical therapy. The company operates through Prevention and Recovery, and Reconstructive segments. Its Prevention and Recovery segment offers orthopedic solutions and recovery sciences including rigid and soft orthopedic bracing, hot and cold therapy, bone growth stimulators, vascular therapy systems and compression garments, therapeutic shoes and inserts, electrical stimulators management, and physical therapy products which are used by orthopedic specialists, surgeons, primary care physicians, pain management specialists, physical therapists, podiatrists, chiropractors, athletic trainers, and other healthcare professionals. The company's Reconstructive segment operates surgical implant business, which includes a suite of reconstructive joint products for the hip, knee, shoulder, elbow, foot, ankle, and finger, as well as surgical productivity tools. The company distributes its products through independent distributors and directly under the ESAB and DJO brands. Enovis Corporation was formerly known as Colfax Corporation. The company was founded in 1995 and is headquartered in Wilmington, Delaware.